CAS: 35973-17-2; 8-Bromo-4-Hydroxy-3-Quinolinecarboxylic Acid

该化合物是一种化学化合物,其特点是其quinoline结构,其特点是8位置的溴原子,4位置的氢氧基,该化合物以潜在的生物活动而闻名,特别是在药用化学中,该化合物可能具有抗微生物或抗炎特性;箱式酸功能组的存在增强了其在极地溶剂中的溶性,有助于其再活动,允许其进行各种化学修改;其分子结构允许氢化碳结合,因为氢化物组会影响其与生物目标的相互作用;此外,该溴替代组可能影响化合物的电子特性和再活动,使其成为有机合成中有价值的中间体;与许多quinoline衍生物一样,它也可能对制药或农业化学物的开发感兴趣;由于溴化化合物的潜在毒性,应当观测安全和处理预防措施.

结构式图片

相似化合物

35975-57-6 98948-95-9 860205-92-1

欧盟法规

C&L通报

上下游产品

8-溴-4-羟基喹啉-3-羧酸乙酯 Ethyl 8-Bromo-4-Oxo-1,4-Dihydroquinoline-3-Carboxylate 35975-57-6

合成工艺路线路线简述

    📜2-[(2-Bromo-Phenylamino)Methylene]Malonic Acid Diethyl Ester置于sodium Hydroxide体系中,用 二苯醚,水 作为反应溶剂,化学反应 5.0H,反应生成 8-溴-4-羟基喹啉-3-羧酸
    参考文献:Investigations On The 4-Quinolone-3-Carboxylic Acid Motif. 4. Identification Of New Potent And Selective Ligands For The Cannabinoid Type 2 Receptor With Diverse Substitution Patterns And Antihyperalgesic Effects In Mice
    标题:Investigations On The 4-Quinolone-3-Carboxylic Acid Motif. 4. Identification Of New Potent And Selective Ligands For The Cannabinoid Type 2 Receptor With Diverse Substitution Patterns And Antihyperalgesic Effects In Mice
    摘要:Experimental Evidence Suggests That Selective Cb2 Receptor Modulators May Provide Access To Antihyperalgesic Agents Devoid Of Psychotropic Effects. Talcing Advantage Of Previous Findings On Structure-Activity/selectivity Relationships For A Class Of 4-Quinolone-3-Carboxamides,Further Structural Modifications Of The Heterocyclic Scaffold Were Explored,Leading To The Discovery Of The 8-Methoxy Derivative 4A Endowed With The Highest Affinity And Selectivity Ever Reported For A Cb2 Ligand. The Compound,Evaluated In Vivo In The Formalin Test,Behaved As An Inverse Agonist By Reducing At A Dose Of 6 Mg/kg The Second Phase Of The Formalin-Induced Nocifensive Response In Mice.
    DOI:10.1021/jm200476P

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/jm050048t
    摘要:Golub AG, Yakovenko OY, Bdzhola VG, Sapelkin VM, Zien P, Yarmoluk SM. Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2. J Med Chem. 2006 Nov 02;49(22):6443–50. doi: 10.1021/jm050048t.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知